BioDot Ltd. has Relocated to New Premises
News Oct 07, 2005
BioDot Ltd has announced that it has relocated its European headquarters. The relocation expands BioDot’s sales and support capabilities in Europe.
Andrew Sweet, BioDot Ltd's Managing Director, comments, "The investment BioDot has put into the facility will enable it to meets its expansion objectives over the next 5 years, both in terms of physical size, and for the improvement in applications, service and sales support."
John Witton, BioDot Ltd's Sales Director adds, "In line with our commitment to enable, inspire and educate scientists to commercialise their diagnostic tests, we can now provide the facilities that link R&D with manufacturing."
"Our laboratories are being constructed for lateral flow, immunoblot, biosensor and biochip applications work, as well as providing the environment for One Step One Solution education and technology transfer programmes".
Andy Walker, BioDot Ltd's Technical Sales Manager, comments, "the facility provides more space for demonstrating our equipment range, and for our expanding Support Centre."
"The size allows us to demonstrate our in-line manufacturing lines, particularly for lateral flow, biosensor and dry chemistry applications. We are seeing increased demand for our dispensing technologies for molecular diagnostic applications, and the OSOS programmes, coupled with the laboratory facility, will allow us to locally support our European customers."
Immediate contact details are:
Downs Road, West Stoke,
Chichester, West Sussex PO18 9HJ
Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood.READ MORE